Access to the 340B Drug Pricing Program: is there evidence of strategic hospital behavior?
- PMID: 34082835
- PMCID: PMC8176719
- DOI: 10.1186/s13104-021-05642-4
Access to the 340B Drug Pricing Program: is there evidence of strategic hospital behavior?
Abstract
Objective: The 340B Drug Pricing Program allows hospitals to purchase covered drugs at a discount and potentially generate profit if they are reimbursed at rates that exceed 340B acquisition prices. Disproportionate share hospitals (DSH) are eligible to participate in 340B if their DSH adjustment-a measure that identifies hospitals that treat a disproportionate share of low income Medicare or Medicaid patients-is above 11.75%. To assess whether hospitals behave strategically to gain access to the program, we examined data on the number of hospitals just above versus below the DSH adjustment threshold for 340B eligibility and conducted McCrary density tests to assess statistical significance.
Results: In 2014-2016, the number of hospitals increases by 41% just above the 340B eligibility threshold. McCrary density tests found this increase to be statistically significant across a range of bandwidths in 2014-2016 (p < 0.01). From 2011-2013, the findings are sensitive to the bandwidth around the threshold, but insignificant in 2008-2010. We found no comparable change among hospitals ineligible for the 340B program. These data are consistent with the hypothesis that some hospitals adjust their DSH to gain 340B eligibility. Our findings support recent calls from the Government Accountability Office to improve oversight of the 340B program.
Keywords: 340B; Hospitals; Policy; Strategic behavior.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures


Similar articles
-
Assessing the Impact of the 340B Drug Pricing Program: A Scoping Review of the Empirical, Peer-Reviewed Literature.Milbank Q. 2024 Jun;102(2):429-462. doi: 10.1111/1468-0009.12691. Epub 2024 Jan 28. Milbank Q. 2024. PMID: 38282421 Free PMC article.
-
Consequences of the 340B Drug Pricing Program.N Engl J Med. 2018 Feb 8;378(6):539-548. doi: 10.1056/NEJMsa1706475. Epub 2018 Jan 24. N Engl J Med. 2018. PMID: 29365282 Free PMC article.
-
A comparison of medication access services at 340B and non-340B hospitals.Res Social Adm Pharm. 2021 Nov;17(11):1887-1892. doi: 10.1016/j.sapharm.2021.03.010. Epub 2021 Mar 20. Res Social Adm Pharm. 2021. PMID: 33846100 Review.
-
Association of Beneficiary-Level Risk Factors and Hospital-Level Characteristics With Medicare Part B Drug Spending Differences Between 340B and Non-340B Hospitals.JAMA Netw Open. 2022 Feb 1;5(2):e220045. doi: 10.1001/jamanetworkopen.2022.0045. JAMA Netw Open. 2022. PMID: 35179584 Free PMC article.
-
Revenues and Profits From Medicare Patients in Hospitals Participating in the 340B Drug Discount Program, 2013-2016.JAMA Netw Open. 2019 Oct 2;2(10):e1914141. doi: 10.1001/jamanetworkopen.2019.14141. JAMA Netw Open. 2019. PMID: 31664442 Free PMC article.
Cited by
-
US Hospital Service Availability and New 340B Program Participation.JAMA Health Forum. 2024 May 3;5(5):e240833. doi: 10.1001/jamahealthforum.2024.0833. JAMA Health Forum. 2024. PMID: 38700853 Free PMC article.
-
Local population characteristics and access equity of 340B contract pharmacies.Health Aff Sch. 2025 Jun 11;3(7):qxaf117. doi: 10.1093/haschl/qxaf117. eCollection 2025 Jul. Health Aff Sch. 2025. PMID: 40625868 Free PMC article.
-
The impacts of the 340B Program on health care quality for low-income patients.Health Serv Res. 2023 Oct;58(5):1089-1097. doi: 10.1111/1475-6773.14204. Epub 2023 Jul 20. Health Serv Res. 2023. PMID: 37475113 Free PMC article.
-
Assessing the Impact of the 340B Drug Pricing Program: A Scoping Review of the Empirical, Peer-Reviewed Literature.Milbank Q. 2024 Jun;102(2):429-462. doi: 10.1111/1468-0009.12691. Epub 2024 Jan 28. Milbank Q. 2024. PMID: 38282421 Free PMC article.
-
Trends in Proportion of Medicare Part D Claims Subject to 340B Discounts, 2013-2020.JAMA Health Forum. 2023 Nov 3;4(11):e234091. doi: 10.1001/jamahealthforum.2023.4091. JAMA Health Forum. 2023. PMID: 37976048 Free PMC article.
References
-
- US Government Accountability Office. Medicare Part B Drugs: Action Needed to Reduce Financial Incentives to Prescribe 340B Drugs at Participating Hospitals. 2015;GAO-15–442.
-
- PHSA. §340(B)(a)(4)(L)(i).
-
- Limitation on prices of drugs purchased by covered entities. 42 U.S.C. §256b(4)(L)(i).
-
- Health Resources & Services Administration. 340B Eligibility. 2018. https://www.hrsa.gov/opa/eligibility-and-registration/index.html.
-
- United States Government Accountability Office. 340B Drug Discount Program: Increased Oversight Needed to Ensure Nongovernmental Hospitals Meet Eligibility Requirements. 2019. Report No.: GAO-20–108.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical